Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human HTT Protein, N-His

Catalog #:   YHE38301 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P42858
Protein length: Ser803-Lys941
Overview

Catalog No.

YHE38301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser803-Lys941

Predicted molecular weight

17.99 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P42858

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Huntingtin, HD protein, Huntington disease protein, HTT, HD, IT15

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human HTT protein
References

Restoring endogenous Dlg4/PSD95 expression by an artificial transcription factor ameliorates cognitive and motor learning deficits in the R6/2 mouse model of Huntington's disease., PMID:40506760

Direct Observation of Secondary Nucleation in Huntingtin Amyloid Formation by High-Speed Atomic Force Microscopy., PMID:40505012

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease highlight shared and tissue-specific effects., PMID:40490511

Genetic Inactivation of the Serotonin Transporter Dysregulates Expression of Neurotransmission Genes and Genome-Wide DNA Methylation Levels in the Medial Prefrontal Cortex of Male Rats During Postnatal Development., PMID:40485115

Concentration-dependent structural transition of huntingtin protein in Huntington's disease., PMID:40482382

Navigating the neuronal recycling bin: Another look at huntingtin in coordinating autophagy., PMID:40475846

Accurate Quantification of Mutant and Wild-Type polyQ Proteins Using Simple Western Capillary Immunoassays., PMID:40450087

Base editing of trinucleotide repeats that cause Huntington's disease and Friedreich's ataxia reduces somatic repeat expansions in patient cells and in mice., PMID:40419681

The influence of genetic factors on the severity of anxiety and depressive symptoms and the choice of coping strategies in reproductive tract cancer-a preliminary study., PMID:40416692

Microbiota dysbiosis impact on the immune system dysregulation in Huntington's disease (HD)., PMID:40414643

Evidence of an unprecedented cytoplasmic function of DDX11, the Warsaw breakage syndrome DNA helicase, in regulating autophagy., PMID:40413757

A potential role for NADPH oxidase (NOX1/2) in mutant huntingtin-induced anomalous neurite outgrowth., PMID:40412581

mTOR inhibition in Q175 Huntington's disease model mice facilitates neuronal autophagy and mutant huntingtin clearance., PMID:40392702

Berberine can be a Potential Therapeutic Agent in Treatment of Huntington's Disease: A Proposed Mechanistic Insight., PMID:40377895

Genetic variants of SLC6A4 and risk of coronary artery disease: insights from North Indian population., PMID:40369544

Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington's Disease., PMID:40358175

Cerulenin Partially Corrects the Disrupted Developmental Transcriptomic Signature in Huntington's Disease Striatal Medium Spiny Neurons., PMID:40336225

Huntingtin inclusion bodies have distinct immunophenotypes and ubiquitination profiles in the Huntington's disease human cerebral cortex., PMID:40319093

Exploring the association between serotonin transporter promoter region methylation levels and depressive symptoms: a systematic review and multi-level meta-analysis., PMID:40319044

Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer's disease and related dementias., PMID:40318118

Immobilizing the Endogenous 5-Hydroxytryptamine Transporter by Ligand-Directed and Proximity-Catalyzed Acyl Imidazole Chemistry for Affinity Chromatographic Analysis., PMID:40317770

Regulation of misfolded protein aggregation and degradation by SUMOylation in budding yeast., PMID:40305096

PRMT5 promotes full-length HTT expression by repressing multiple proximal intronic polyadenylation sites., PMID:40304179

[Finally, an understanding of Huntington's disease!]., PMID:40293154

Regulation of Genome Architecture in Huntington's Disease., PMID:40287840

Antioxidant and Anti-Inflammatory Defenses in Huntington's Disease: Roles of NRF2 and PGC-1α, and Therapeutic Strategies., PMID:40283130

Kinetin mediated mutant huntingtin phosphorylation restores multiple dysregulated pathways in a cell line model of Huntington's disease., PMID:40267238

Opposing roles for GSK3β and ERK1-dependent phosphorylation of huntingtin during neuronal dysfunction and cell death in Huntington's disease., PMID:40263294

Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification., PMID:40259428

Intersecting impact of CAG repeat and huntingtin knockout in stem cell-derived cortical neurons., PMID:40258535

Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates fibril-induced cellular stress., PMID:40234398

Altered huntingtin-chromatin interactions predict transcriptional and epigenetic changes in Huntington's disease., PMID:40205980

Mutant huntingtin induces neuronal apoptosis via derepressing the non-canonical poly(A) polymerase PAPD5., PMID:40204699

Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights., PMID:40202221

Multi-epitope immunocapture of huntingtin reveals striatum-selective molecular signatures., PMID:40169779

Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review., PMID:40138119

Hyalinizing trabecular tumor of the thyroid: Interest of GLIS3 immunohistochemical study to detect PAX8::GLIS3 rearrangement., PMID:40122401

Structural-functional analyses of the huntingtin/HAP40 complex in Drosophila and humans., PMID:40091796

Transcriptomic analysis of intracellular RNA granules and small extracellular vesicles: Unmasking their overlap in a cell model of Huntington's disease., PMID:40090627

The breaking point where repeat expansion triggers neuronal collapse in Huntington's disease., PMID:40081335

CAG Repeat Instability and Region-Specific Gene Expression Changes in the SCA12 Brain., PMID:40075006

Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons., PMID:40060574

Downregulation of Pten Improves Huntington's Disease Phenotype by Reducing Htt Aggregates and Cell Death., PMID:40042729

The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3β inhibition., PMID:40011132

Transcriptome Study in Sicilian Patients with Huntington's Disease., PMID:40002561

Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review., PMID:40001897

Multiple Copper Ions Bind to and Promote the Oligomerization of Huntingtin Protein with Nonpathological Repeat Expansions., PMID:39984289

Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregation., PMID:39973391

Revisiting huntingtin activity and localization signals in the context of protein structure., PMID:39973382

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human HTT Protein, N-His [YHE38301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only